|
|
|
|
|
|
|
|
| Regulatory Affairs |
|
|
Roll Up! Another European Drug Pricing Spat! |
The external reference pricing circus has rolled back into town, promising another great European show. The fight-back comes via one of Europe's most obscure bodies, the European Integrated Price Information Database—better known as Euripid.
... /Read more/ |
|
|
|
|
| Advertisement |
5 Benefits of Liquidating Your Fleet Vehicles
On the surface giving your sales reps vehicles might seem like a great idea, but in fact there are many issues hiding in a fleet program. Is your fleet program a money pit? Reimbursing for business mileage is an alternative that not only pays off for you but for your sales reps too. Discover the
 5 benefits of transitioning from a fleet to vehicle reimbursement.
|
|
| Emerging Markets |
 |
|
The New Age of BioDigital Pharma
|
It's no longer sufficient for a pharma to develop better products or even build simple apps. The industry increasingly needs to create sophisticated predictive algorithms to maximize the ability of its products, write Tom Agan and Fred Geyer.
... /Read more/ |
|
|
| Advertisement |
2017 Real-World Evidence Benchmark Survey
Deloitte's 2017 Real-World Evidence Benchmark Survey shows that life sciences companies are making some progress in using RWE but still have opportunities to expand applications across the value chain, consider new channels to access RWD, and improve their overall capabilities.
 Explore this research Today!
|
|
| Advertisement |
Winning the RAT race: A new Center of Excellence to drive development of regenerative medicines
On Demand
 Learn more
|
|
| Pricing and Reimbursement |
|
|
|
| Calendar |
|
| Advertisement |
Talking the Patients' Language – the importance of effective, patient-centered engagement
Live Webinar: Tuesday, June 6 at 8:00am EDT
 Register now
|
|
 |
|
|
|
|
|
|
|
|
